A, S., N, L., M, B., A, S., F, B., G, C., . . . A, M. (2025). Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease. Cell death & disease, 16(1), 57. https://doi.org/10.1038/s41419-025-07331-7
Chicago Style (17th ed.) CitationA, Smiriglia, Lorito N, Bacci M, Subbiani A, Bonechi F, Comito G, Kowalik MA, Perra A, and Morandi A. "Estrogen-dependent Activation of TRX2 Reverses Oxidative Stress and Metabolic Dysfunction Associated with Steatotic Disease." Cell Death & Disease 16, no. 1 (2025): 57. https://doi.org/10.1038/s41419-025-07331-7.
MLA (9th ed.) CitationA, Smiriglia, et al. "Estrogen-dependent Activation of TRX2 Reverses Oxidative Stress and Metabolic Dysfunction Associated with Steatotic Disease." Cell Death & Disease, vol. 16, no. 1, 2025, p. 57, https://doi.org/10.1038/s41419-025-07331-7.